---
name: Cardiomedex
slug: cardiomedex
site: cro
website_domain: cardiomedex.com
summary: Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications. Headquartered in Toulouse, France.
tagline: Preclinical CRO specialized in cardiovascular disease models and cardiometabolic efficacy studies.
founded_year: 
employee_count_band: 
employee_count_label: 
parent_name: 
parent_slug: 
hq_country: FR
tier2_domain_verified: false
updated_at: 2026-06-17T07:01:41.572Z
services_count: 6
modalities_count: 1
indications_count: 2
locations_count: 1
review_signal_gate: closed
generated_by: BioBM Editorial AI
---

# Cardiomedex

Preclinical CRO specialized in cardiovascular disease models and cardiometabolic efficacy studies.

Listed on cro.directory.

## Summary

Cardiomedex is a preclinical CRO specialized in cardiovascular disease models, offering in vivo efficacy studies, ex vivo functional exploration, and in vitro assays for drug candidates targeting heart failure, myocardial infarction, hypertension, and cardiometabolic complications. Headquartered in Toulouse, France.

## At a glance

- HQ country: FR

## Services

- Cardiovascular & Metabolic Specialty Services
- In Vivo Efficacy Models
- Preclinical In Vivo Studies
- In Vitro Pharmacology
- Preclinical In Vitro Studies
- Translational Research

## Modalities

- Small Molecule

## Indications

- Cardiovascular
- Metabolic

## Locations

- Headquarters, Toulouse, France

## Long description

## Overview

Cardiomedex is a preclinical contract research organization (CRO) headquartered near Toulouse, France, with specialized expertise in cardiovascular and cardiometabolic disease modeling. The organization conducts reliable preclinical studies to optimize drug candidate development for cardiovascular indications.

## Capabilities

**In Vivo Models & Studies**
- Gold standard animal models covering cardiovascular disorders including:
  - Heart failure with preserved ejection fraction (HFpEF) and reduced ejection fraction (HFrEF)
  - Myocardial infarction
  - Cardiac hypertrophy
  - Hypertension
  - Endothelial dysfunction
  - Anthracycline cardiotoxicity
- Translational models incorporating multiple common risk factors (NASH, diabetic nephropathy, metabolic syndrome, type 2 diabetes)
- Physio-pathological models for in vivo functional exploration

**In Vitro & Ex Vivo Assays**
- State-of-the-art platform for functional exploration and pharmacological characterization
- Molecular screening using BRET-based technology
- Ex vivo and in vitro assay capabilities

**Consulting & Strategic Services**
- Personalized consulting aligned with emerging pharma industry trends
- Drug repurposing and repositioning support
- Research timeline and productivity optimization

## Facilities

Cardiomedex operates brand new facilities shared with Physiogenex, equipped with appropriate devices to ensure high-quality CRO services and reliable study results.

_Profile last updated: 2026-06-17T07:01:41.572Z. Profile facts may include AI-assisted enrichment._

Auto-generated by BioBM Editorial AI for machine-readable profile access.